Hair loss has long confounded the pharmaceutical industry, but there’s hope on the horizon. Veradermics has announced success in its late-stage clinical trial with a drug to reverse hair loss. The ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. As GLP‑1 weight‑loss drugs move into the medical mainstream, experts ...

President Donald Trump once promised lower prices on blockbuster weight-loss drugs in exchange for expanding access through Medicare. Now, that plan is on hold. The Trump administration has ...

Blockbuster weight-loss drugs cause muscle loss exceeding clinician expectations, according to findings presented at the American College of Physicians Internal Medicine (ACP-IM) Meeting in San ...

The first time Caroline went on Wegovy, it wasn’t a secret: She told her boyfriend, mother, and close friends. Over the course of six months, they watched as she shed 30 pounds, going from 130 back to ...

The state Senate passed a bill Friday regulating copycat versions of popular weight loss drugs like Ozempic and Wegovy. The bill would require compounding pharmacies that make so-called GLP-1 drugs to ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...

A common acne medication may do more than clear skin. In a late-stage clinical trial, a higher concentration of it helped men with androgenetic alopecia (AGA) regrow and retain hair, with effects ...

Please provide your email address to receive an email when new articles are posted on . Muscle loss was greater in adults given GLP-1s vs. those treated with either placebo or lifestyle interventions.